Health Condition 1: G55- Nerve root and plexus compressionsin diseases classified elsewhere
Conditions
Interventions
Intervention1: Nil: Nil
Sponsors
AIIMS Kalyani
Eligibility
Inclusion criteria
Inclusion criteria: 1. Previous Spine Surgery: History of lumbar spine surgery at L4-L5, L5-S1. 2. Systemic or Local Infection: Presence of localized skin infection at the injection site or systemic infection. 3. Coagulopathy or Anticoagulant Therapy: Patients with bleeding disorders or those on anticoagulant medication without proper management. 4. Severe Neurological Deficits: Progressive motor weakness, cauda equina syndrome, or loss of bowel/bladder control. 5. Allergy to Medications: Known allergy to local anesthetics, steroids. 6. Non-Radicular Pain: Patients with purely mechanical low back pain without radiating leg symptoms. 7. Severe Comorbidities: Uncontrolled diabetes, severe cardiovascular disease, or malignancy. 8. Pregnancy or Lactation: Pregnant or breastfeeding women are usually excluded to avoid potential harm. 9. Psychiatric Disorders: Severe psychiatric illnesses that may impair pain reporting or study compliance. 10. Substance Abuse:Current or recent history of substance abuse (alcohol, opioids, or recreational drugs). 11. Sacrococcygeal tumor or fractures. 12. Patient on chronic steroids, DMARD s & opioids.
Exclusion criteria
Exclusion criteria: 1. Previous Spine Surgery: History of lumbar spine surgery at L4-L5, L5-S1. 2. Systemic or Local Infection: Presence of localized skin infection at the injection site or systemic infection. 3. Coagulopathy or Anticoagulant Therapy: Patients with bleeding disorders or those on anticoagulant medication without proper management. 4. Severe Neurological Deficits: Progressive motor weakness, cauda equina syndrome, or loss of bowel/bladder control. 5. Allergy to Medications: Known allergy to local anesthetics, steroids. 6. Non-Radicular Pain: Patients with purely mechanical low back pain without radiating leg symptoms. 7. Severe Comorbidities: Uncontrolled diabetes, severe cardiovascular disease, or malignancy. 8. Pregnancy or Lactation: Pregnant or breastfeeding women are usually excluded to avoid potential harm. 9. Psychiatric Disorders: Severe psychiatric illnesses that may impair pain reporting or study compliance. 10. Substance Abuse:Current or recent history of substance abuse (alcohol, opioids, or recreational drugs). 11. Sacrococcygeal tumor or fractures. 12. Patient on chronic steroids, DMARD s & opioids.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NERVE CONDUCTION STUDY Distal Latency, aplitude, f wave latency of tibial and common peroneal nerve H reflex latencyTimepoint: AT BASELINE 2 WEEKS 4 WEEKS 6 WEEKS | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analog scale to assess changes in symptom of painTimepoint: AT BASELINE 2 WEEKS 4 WEEKS 6 WEEKS;Oswestry disability Index to assess changes in disability caused by pain to the patinetTimepoint: AT BASELINE 2 WEEKS 4 WEEKS 6 WEEKS | — |
Countries
India
Contacts
Public ContactSamriddhi Keshkar
AIIMS Kalyani
Outcome results
None listed